Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

515 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Linkage between patients' characteristics and prescribed systemic treatments for psoriasis: a semantic connectivity map analysis of the Swiss Dermatology Network for Targeted Therapies registry.
Cazzaniga S, Anzengruber F, Augustin M, Boehncke WH, Borradori L, Conrad C, Cozzio A, Djamei V, French LE, Gilliet M, Häusermann P, Heidemeyer K, Itin P, Kolios AGA, Laffitte E, Maul JT, Mainetti C, Naldi L, Navarini AA, Rustenbach SJ, Simon D, Sorbe C, Streit M, Yawalkar N. Cazzaniga S, et al. Among authors: naldi l. J Eur Acad Dermatol Venereol. 2019 Dec;33(12):2313-2318. doi: 10.1111/jdv.15983. Epub 2019 Oct 28. J Eur Acad Dermatol Venereol. 2019. PMID: 31562785
Psoriasis.
Naldi L. Naldi L. Dermatol Clin. 1995 Jul;13(3):635-47. Dermatol Clin. 1995. PMID: 7554511 Review.
Randomized controlled trial comparing the effectiveness of 308-nm excimer laser alone or in combination with topical hydrocortisone 17-butyrate cream in the treatment of vitiligo of the face and neck.
Sassi F, Cazzaniga S, Tessari G, Chatenoud L, Reseghetti A, Marchesi L, Girolomoni G, Naldi L. Sassi F, et al. Among authors: naldi l. Br J Dermatol. 2008 Nov;159(5):1186-91. doi: 10.1111/j.1365-2133.2008.08793.x. Epub 2008 Aug 19. Br J Dermatol. 2008. PMID: 18717675 Clinical Trial.
Incidence of bullous pemphigoid and pemphigus in Switzerland: a 2-year prospective study.
Marazza G, Pham HC, Schärer L, Pedrazzetti PP, Hunziker T, Trüeb RM, Hohl D, Itin P, Lautenschlager S, Naldi L, Borradori L; Autoimmune bullous disease Swiss study group. Marazza G, et al. Among authors: naldi l. Br J Dermatol. 2009 Oct;161(4):861-8. doi: 10.1111/j.1365-2133.2009.09300.x. Epub 2009 May 8. Br J Dermatol. 2009. PMID: 19566661
European S3-guidelines on the systemic treatment of psoriasis vulgaris.
Pathirana D, Ormerod AD, Saiag P, Smith C, Spuls PI, Nast A, Barker J, Bos JD, Burmester GR, Chimenti S, Dubertret L, Eberlein B, Erdmann R, Ferguson J, Girolomoni G, Gisondi P, Giunta A, Griffiths C, Hönigsmann H, Hussain M, Jobling R, Karvonen SL, Kemeny L, Kopp I, Leonardi C, Maccarone M, Menter A, Mrowietz U, Naldi L, Nijsten T, Ortonne JP, Orzechowski HD, Rantanen T, Reich K, Reytan N, Richards H, Thio HB, van de Kerkhof P, Rzany B. Pathirana D, et al. Among authors: naldi l. J Eur Acad Dermatol Venereol. 2009 Oct;23 Suppl 2:1-70. doi: 10.1111/j.1468-3083.2009.03389.x. J Eur Acad Dermatol Venereol. 2009. PMID: 19712190
Mortality of bullous pemphigoid in Switzerland: a prospective study.
Cortés B, Marazza G, Naldi L, Combescure C, Borradori L; Autoimmune Bullous Disease Swiss Study Group. Cortés B, et al. Among authors: naldi l. Br J Dermatol. 2011 Aug;165(2):368-74. doi: 10.1111/j.1365-2133.2011.10413.x. Br J Dermatol. 2011. PMID: 21574978
Methotrexate, a drug for the years to come.
Naldi L, Saunes M. Naldi L, et al. Br J Dermatol. 2011 Aug;165(2):230-1. doi: 10.1111/j.1365-2133.2011.10420.x. Br J Dermatol. 2011. PMID: 21777212 No abstract available.
515 results